|
Delayed
Nasdaq Stockholm
12:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 9.110 SEK | -2.04% |
|
+1.33% | -32.52% |
| 09-17 | Vivesto sees tumor effect with Paccal Vet in cat study | FW |
| 09-17 | Vivesto reports positive topline results from the Paccal Vet feline study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
